| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 51,298 | 77,711 | 50,987 | 41,407 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 77,711 | 50,987 | 41,407 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 127,667 | 440,048 | 110,988 | 186,738 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 27,750 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (107,910) | (362,337) | (60,001) | (145,331) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (104,119) | (362,337) | (60,001) | (145,331) | | Interest Expense | 1,202 | 1,895 | 694 | 694 | | Income Before Tax | (105,321) | (364,232) | (60,695) | (146,025) | | Income Tax Expense | (3,426) | (4,813) | (5,521) | (23,818) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (101,895) | (359,419) | (55,174) | (122,207) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (101,895) | (359,419) | (55,174) | (122,207) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($101,895) | ($359,419) | ($55,174) | ($122,207) |
|
0.51% Nasdaq 
Income Statement
